Characteristics of Changes in Intrathecal Baclofen Dosage over Time due to Causative Disease
Yuki Kimoto(The University of Osaka), Haruhiko Kishima(Osaka University Hospital), Hui Ming Khoo(The University of Osaka), Yuji ONODA(The University of Osaka), Takufumi Yanagisawa(The University of Osaka), Takamasa Ishiuchi(The University of Osaka), Yuya Fujita(The University of Osaka), Satoru Oshino(The University of Osaka), Takuto Emura(The University of Osaka), Koichi Hosomi(RELX Group (Netherlands)), Masayuki HIRATA(The University of Osaka), Takahiro Matsuhashi(The University of Osaka), Naoki Tani(Osaka Gakuin University), Shimpei Miura(The University of Osaka), Takamitsu Iwata(The University of Osaka)
Cited by 2
Related Papers
PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria
|Nature Communications|2012|599
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
|The Lancet|2014|436
MEIOSIN Directs the Switch from Mitosis to Meiosis in Mammalian Germ Cells
|Developmental Cell|2020|211